70 related articles for article (PubMed ID: 16254158)
1. Medicine. Fused genes may help explain the origins of prostate cancer.
Marx J
Science; 2005 Oct; 310(5748):603. PubMed ID: 16254158
[No Abstract] [Full Text] [Related]
2. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.
Tomlins SA; Rhodes DR; Perner S; Dhanasekaran SM; Mehra R; Sun XW; Varambally S; Cao X; Tchinda J; Kuefer R; Lee C; Montie JE; Shah RB; Pienta KJ; Rubin MA; Chinnaiyan AM
Science; 2005 Oct; 310(5748):644-8. PubMed ID: 16254181
[TBL] [Abstract][Full Text] [Related]
3. Confirmation of the high frequency of the TMPRSS2/ERG fusion gene in prostate cancer.
Soller MJ; Isaksson M; Elfving P; Soller W; Lundgren R; Panagopoulos I
Genes Chromosomes Cancer; 2006 Jul; 45(7):717-9. PubMed ID: 16575875
[No Abstract] [Full Text] [Related]
4. TMPRSS2:ERG fusion by translocation or interstitial deletion is highly relevant in androgen-dependent prostate cancer, but is bypassed in late-stage androgen receptor-negative prostate cancer.
Hermans KG; van Marion R; van Dekken H; Jenster G; van Weerden WM; Trapman J
Cancer Res; 2006 Nov; 66(22):10658-63. PubMed ID: 17108102
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive detection of TMPRSS2:ERG fusion transcripts in the urine of men with prostate cancer.
Laxman B; Tomlins SA; Mehra R; Morris DS; Wang L; Helgeson BE; Shah RB; Rubin MA; Wei JT; Chinnaiyan AM
Neoplasia; 2006 Oct; 8(10):885-8. PubMed ID: 17059688
[TBL] [Abstract][Full Text] [Related]
6. Significance of the TMPRSS2:ERG gene fusion in prostate cancer.
Hossain D; Bostwick DG
BJU Int; 2013 May; 111(5):834-5. PubMed ID: 23578235
[No Abstract] [Full Text] [Related]
7. Three-color FISH analysis of TMPRSS2/ERG fusions in prostate cancer indicates that genomic microdeletion of chromosome 21 is associated with rearrangement.
Yoshimoto M; Joshua AM; Chilton-Macneill S; Bayani J; Selvarajah S; Evans AJ; Zielenska M; Squire JA
Neoplasia; 2006 Jun; 8(6):465-9. PubMed ID: 16820092
[TBL] [Abstract][Full Text] [Related]
8. Studies of TMPRSS2-ERG gene fusions in diagnostic trans-rectal prostate biopsies.
Attard G; de Bono JS; Clark J; Cooper CS
Clin Cancer Res; 2010 Feb; 16(4):1340; author reply 1340. PubMed ID: 20145164
[No Abstract] [Full Text] [Related]
9. TMPRSS2-ERG gene fusion causing ERG overexpression precedes chromosome copy number changes in prostate carcinomas and paired HGPIN lesions.
Cerveira N; Ribeiro FR; Peixoto A; Costa V; Henrique R; Jerónimo C; Teixeira MR
Neoplasia; 2006 Oct; 8(10):826-32. PubMed ID: 17032499
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer: Stuck in the middle: interstitial genes in TMPRSS2-ERG fusion.
Stone L
Nat Rev Urol; 2018 Jan; 15(1):3. PubMed ID: 29205202
[No Abstract] [Full Text] [Related]
11. Morphological features of TMPRSS2-ERG gene fusion prostate cancer.
Mosquera JM; Perner S; Demichelis F; Kim R; Hofer MD; Mertz KD; Paris PL; Simko J; Collins C; Bismar TA; Chinnaiyan AM; Rubin MA
J Pathol; 2007 May; 212(1):91-101. PubMed ID: 17385188
[TBL] [Abstract][Full Text] [Related]
12. TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic reprogramming.
Iljin K; Wolf M; Edgren H; Gupta S; Kilpinen S; Skotheim RI; Peltola M; Smit F; Verhaegh G; Schalken J; Nees M; Kallioniemi O
Cancer Res; 2006 Nov; 66(21):10242-6. PubMed ID: 17079440
[TBL] [Abstract][Full Text] [Related]
13. Multiple genomic alterations on 21q22 predict various TMPRSS2/ERG fusion transcripts in human prostate cancers.
Liu W; Ewing CM; Chang BL; Li T; Sun J; Turner AR; Dimitrov L; Zhu Y; Sun J; Kim JW; Zheng SL; Isaacs WB; Xu J
Genes Chromosomes Cancer; 2007 Nov; 46(11):972-80. PubMed ID: 17654723
[TBL] [Abstract][Full Text] [Related]
14. ETS transcription factors and prostate cancer: the role of the family prototype ETS-1 (review).
Adler D; Wernert N
Int J Oncol; 2012 Jun; 40(6):1748-54. PubMed ID: 22366814
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive assessment of DNA copy number alterations in human prostate cancers using Affymetrix 100K SNP mapping array.
Liu W; Chang B; Sauvageot J; Dimitrov L; Gielzak M; Li T; Yan G; Sun J; Sun J; Adams TS; Turner AR; Kim JW; Meyers DA; Zheng SL; Isaacs WB; Xu J
Genes Chromosomes Cancer; 2006 Nov; 45(11):1018-32. PubMed ID: 16897747
[TBL] [Abstract][Full Text] [Related]
16. A universal assay for detection of oncogenic fusion transcripts by oligo microarray analysis.
Skotheim RI; Thomassen GO; Eken M; Lind GE; Micci F; Ribeiro FR; Cerveira N; Teixeira MR; Heim S; Rognes T; Lothe RA
Mol Cancer; 2009 Jan; 8():5. PubMed ID: 19152679
[TBL] [Abstract][Full Text] [Related]
17. ERG upregulation and related ETS transcription factors in prostate cancer.
Rostad K; Mannelqvist M; Halvorsen OJ; Oyan AM; Bø TH; Stordrange L; Olsen S; Haukaas SA; Lin B; Hood L; Jonassen I; Akslen LA; Kalland KH
Int J Oncol; 2007 Jan; 30(1):19-32. PubMed ID: 17143509
[TBL] [Abstract][Full Text] [Related]
18. Integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancer.
Weischenfeldt J; Simon R; Feuerbach L; Schlangen K; Weichenhan D; Minner S; Wuttig D; Warnatz HJ; Stehr H; Rausch T; Jäger N; Gu L; Bogatyrova O; Stütz AM; Claus R; Eils J; Eils R; Gerhäuser C; Huang PH; Hutter B; Kabbe R; Lawerenz C; Radomski S; Bartholomae CC; Fälth M; Gade S; Schmidt M; Amschler N; Haß T; Galal R; Gjoni J; Kuner R; Baer C; Masser S; von Kalle C; Zichner T; Benes V; Raeder B; Mader M; Amstislavskiy V; Avci M; Lehrach H; Parkhomchuk D; Sultan M; Burkhardt L; Graefen M; Huland H; Kluth M; Krohn A; Sirma H; Stumm L; Steurer S; Grupp K; Sültmann H; Sauter G; Plass C; Brors B; Yaspo ML; Korbel JO; Schlomm T
Cancer Cell; 2013 Feb; 23(2):159-70. PubMed ID: 23410972
[TBL] [Abstract][Full Text] [Related]
19. [Dangerous liaisons in prostate cancer. Clinical and biological implications of recurrent gene fusions].
Perner S
Pathologe; 2010 Oct; 31 Suppl 2():121-5. PubMed ID: 20798944
[TBL] [Abstract][Full Text] [Related]
20. EWS-FLI1, EWS-ERG, and EWS-ETV1 oncoproteins of Ewing tumor family all suppress transcription of transforming growth factor beta type II receptor gene.
Im YH; Kim HT; Lee C; Poulin D; Welford S; Sorensen PH; Denny CT; Kim SJ
Cancer Res; 2000 Mar; 60(6):1536-40. PubMed ID: 10749119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
